INTRODUCTION {#s1}
============

-Breast cancer (BC) affects about 12% of women worldwide. Statistics indicate that almost 3 million women suffers from BC in 2015 in the United States \[[@R1]\]. Risk factors for developing breast cancer include unhealthy lifestyles, other medical conditions and genetic susceptibility \[[@R2], [@R3]\]. Epidemiologic studies suggest that women with family history of BC could be more vulnerable to develop BC cancer than those not \[[@R4], [@R5]\].

Environmental factors and metabolic processes are the two main causes of DNA damage. Ionizing radiation has been confirmed as an environmental risk factor for the development of cancer, which can cause DNA damage of different kinds.\[[@R6]\] Base-excision repair (BER), one of DNA repair pathways, mainly repairs single base in damaged DNA molecule. Mutations occurred in BER related genes can lead to change its repair function, and then increases the probability of developing cancer greatly \[[@R7], [@R8]\].

Numerous studies have widely explored the relationship between susceptibility to BC and single nucleotide polymorphisms (SNPs) in Base-excision repair genes. However, the conclusions remain indecisive as a result of insufficient samples and/or race diversity. These studies include human apurinic/apyrimidinic endonuclease (APE1), x-ray repair cross-complementing 1 (XRCC1), human 8-oxoguanine DNA glycosylase (OGG1, also known as hOGG1), and poly (ADP-ribose) polymerase-1 (ADPAT1, also known as PARP1). Among these, the relationships between risk of BC and mutations of rs25487 and rs1799782 on the XRCC1 gene have caused the greatest controversy among researchers. Positive association between rs25487 mutation \[[@R9]--[@R14]\] and the risk of BC have been reported in single race population studies, but others did not even in the same race \[[@R15]--[@R21]\]. Most studies suggest that the rs1799782 mutation is not associated with developing BC, while other studies report it is positively correlated. \[[@R9], [@R11]--[@R15], [@R17], [@R19]\] Inconsistent results have also been reported in studies using populations consisting of mixed race. Duell *et al.* (2001) reported a positive association for rs25487 with BC was found among African Americans but not Caucasian Americans \[[@R22]\]. VIEIRAL *et al.* (2015) demonstrates genetic background can influence BC developing, even an inverse association \[[@R23]\].

Meta-analysis is an authoritative way to improve authenticity and provides quantitative pooled values for different races. Previous meta-analysis studies adopted the continental location as the classification standard to discuss the relationship between susceptibility to BC and SNPs in BER genes \[[@R24], [@R25]\]. However, there are numerous races distributed on the same continent. For example, the Mongoloid race is mainly located in the East and Southeast of Asia, and the Caucasoid race mainly located in Europe, the Americas, Oceania, North Africa, South and West Asia. Therefore, using human race as the standard of classification to use in stratification analysis may be more appropriate. The purpose of this study is to discuss the relationship between risk of developing BC and BER genes based on genetic ancestry.

MATERIALS AND METHODS {#s2}
=====================

Literature search strategy {#s2_1}
--------------------------

The Medline, PubMed, Embase, Web of Science were searched (the last search was updated on October 20th 2016) using the search terms ''breast cancer'', ''polymorphism'' or "SNP", ''DNA Repair Gene'' or "base excision DNA repair gene" or "BER gene". All searches were retrieved and their references were checked for other relevant publications. Only published studies with full-text articles were included. When more than one of the same patient populations was included in several studies, only the study with the largest sample size or the complete study was used for this meta-analysis. A flow diagram of the study selection process was shown in Figure [1](#F1){ref-type="fig"}.

![A flow diagram of the studies selection process](oncotarget-09-16220-g001){#F1}

Inclusion and exclusion criteria {#s2_2}
--------------------------------

The inclusion and exclusion criteria were established on the basis of discussion and consensus. The inclusion criteria for studies were as follows: (1) case-control studies; (2) the aim was to examine the association of the polymorphisms in BER genes with susceptibility of breast cancer; (3) data provided met the requirements of meta-analysis method; (4) genotype distribution in healthy controls complied with the Hardy--Weinberg equilibrium (HWE).

The exclusion criteria were as follows: (1) did not fit the diagnostic criteria; (2) animal study; (3) the aim of the study didn\`t focus on susceptibility to breast cancer or not BER genes; (5) genotype distribution healthy controls deviated from the HWE.

Racial classification {#s2_3}
---------------------

According to the Meyers Konversations-Lexikon (1885--90), human beings can be divided into three major races: Mongoloid race, Caucasoid race, and Negroid race. The Mongoloid race is a term used for all or some people who are indigenous to East Asia, Central Asia, Southeast Asia, North Asia, South Asia, the Arctic, the Americas, the Pacific Islands and other lesser regions, and are the minority group worldwide (<https://en.wikipedia.org/wiki/Mongoloid>). The Caucasoid race usually includes some or all of the ancient and modern populations of Europe, the Caucasus, Asia Minor, North Africa, the Horn of Africa, Western Asia, Central Asia and South Asia (<https://en.wikipedia.org/wiki/Caucasian_race#cite_note-Pickering-8>). The Negroid race populations are found in most of Sub-Saharan Africa and isolated parts of Southeast Asia (Negritos) (<https://en.wikipedia.org/wiki/Negroid>).

The information included in this meta-analysis was arranged and divided into Mongoloid population, Caucasoid population and Negroid population using the criteria above. If the racial origin of the samples could not be clearly defined, the data was assigned to a mixed race group.

Statistical analysis {#s2_4}
--------------------

A χ^2^ test was used to determine if observed frequencies of genotypes corresponded to the HWE. Statistical analysis was conducted using R software and a *P*-value ≤ 0.05 was considered statistically significant. Dichotomous data was presented as the odds ratio (OR) with a 95% confidence interval (CI). Statistical heterogeneity was measured using the Q-statistic (P ≤ 0.10 was considered to be representative of statistically significant heterogeneity). Effect of heterogeneity quantified by the *I*^2^ statistic, a fixed effects model was used when there was no heterogeneity in the results of the trials; otherwise, the random effects model was used. Egger's weighted regression method were used to statistically assess the publication bias (*P* ≤ 0.05 was considered to indicate statistically significant publication bias). The methods of "Influence analysis" and "Trim and Filled analysis" were both conducted to investigate the sensitivity of the pooled ORs.

RESULTS {#s3}
=======

183 relevant studies with 69 SNPs on 20 BER related genes were retrieved in this research. 114 articles describing 19 genes were excluded from this study due to insufficient publication number (not more than 3 researches). Finally, this study included 69 papers with 33760 BC cases and 33252 controls, and the information was summarized in Table [1](#T1){ref-type="table"}. The flow process was shown in Figure [1](#F1){ref-type="fig"}.

###### Summary of the SNPs studied in this meta-analysis

  Genes in BER pathway   SNPs        n\. of studies included   n\. of Cases   n\. of Controls   References included
  ---------------------- ----------- ------------------------- -------------- ----------------- ------------------------------------------------------------------------------------
  XRCC1                  rs1799782   33                        14991          15624             \[[@R9], [@R10], [@R12], [@R13], [@R16]--[@R23], [@R26]--[@R46]\]
                         rs25487     47                        20995          22964             \[[@R9]--[@R13], [@R15]--[@R22], [@R26], [@R27], [@R29]--[@R45], [@R47]--[@R60]\]
                         rs25489     10                        7509           7403              \[[@R16], [@R19], [@R21], [@R28], [@R32], [@R34], [@R36], [@R43], [@R47], [@R57]\]
  ADPRT1                 rs1805414   3                         236            269               \[[@R61]--[@R63]\]
                         rs1136410   7                         3128           2805              \[[@R28], [@R32], [@R53], [@R61], [@R62], [@R64], [@R65]\]
  APEX1                  rs1130409   12                        5154           5858              \[[@R13], [@R14], [@R28], [@R32], [@R35], [@R36], [@R51], [@R66]--[@R70]\]
                         rs1760944   4                         1415           1827              \[[@R13], [@R14], [@R68], [@R69]\]
  OGG1                   rs1052133   16                        11038          12799             \[[@R14], [@R32], [@R34], [@R36], [@R44], [@R46], [@R57], [@R67], [@R71]--[@R78]\]

Three SNPs on the XRCC1 gene were analysed in this meta-analysis. As [Supplementary Table 1](#SD1){ref-type="supplementary-material"} show, this meta-analysis didn't find any evidence to suggest that mutations in rs25489 and rs1799782 were associated with the susceptibility to develop BC in any race population. But, rs25487 with A allele significantly reduced the risk of developing BC in Mongoloid and Caucasoid populations, but not in the Negroid population (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).

![Forest plot of RS25487 polymorphism in XRCC1 and risk to breast cancer (GA+GG vs. AA) (the model adopted was marked by black frame)](oncotarget-09-16220-g002){#F2}

![Forest plot of RS25487 polymorphism in XRCC1 and risk to breast cancer (G allele vs. A allele) (the model adopted was marked by black frame)](oncotarget-09-16220-g003){#F3}

Two SNPs on the ADPRT1 gene were analysed in this meta-analysis. As Table [2](#T2){ref-type="table"} shows, there is no evidence which indicates that mutations in SNPs of rs1805414 and rs1136410 were significantly associated with BC. The relationship between two SNPs (rs1130409 and rs1760944) on the APEX1 gene and risk of developing BC was analysed in this meta-analysis (Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}).

###### Summary about meta-analysis results of SNPs in ADPRT gene and risk of breast cancer

  ---------------------------------------------------------------------------------------------------------------------------------------------
  SNP               Genetic\          Race        *n*            OR (95% CI)    Homogeneity    *P* for Publication\                     
                    Models                                                                     Bias test                                
  ----------------- ----------------- ----------- -------------- -------------- -------------- ---------------------- -------- -------- -------
  Rs1805414\        TT + CT vs. CC\   Caucasoid   3              0.411          0.134--1.256   0.119                  5.000    61.541   0.628
  TT/ CT/ CC        (Dominant)                                                                                                          

  TT vs. CT + CC\   Caucasoid         3           0.576          0.195--1.702   0.318          17.000                 88.241   0.758    
  (Recessive)                                                                                                                           

  T vs. C\          Caucasoid         3           0.582          0.255--1.33    0.200          16.000                 87.383   0.332    
  (Allele)                                                                                                                              

  TT vs. CT\        Caucasoid         3           0.650          0.207--2.038   0.460          17.000                 87.892   0.566    
  (Co-Dominant)                                                                                                                         

  CT vs. CC\        Caucasoid         3           0.519          0.169--1.595   0.252          5.000                  57.083   0.659    
  (Co-Dominant)                                                                                                                         

  Rs1136410\        CT+CC vs. TT\     Overall     7              1.004          0.787--1.282   0.971                  5.000    0.000    0.188
  CC / CT/ TT       (Dominant)                                                                                                          

  Caucasoid         6                 1.075       0.776--1.487   0.665          4.970          0.000                  0.314             

  CC vs. CT+ TT     Overall           7           0.996          0.781--1.272   0.971          5.000                  0.000    0.683    

  (Recessive)       Caucasoid         6           0.931          0.672--1.288   0.665          4.970                  0.000    0.547    

  C vs. T           Overall           8           0.975          0.822--1.157   0.772          14.000                 48.680   0.147    

  (Allele)          Caucasoid         6           0.999          0.802--1.247   0.628          11.014                 54.605   0.721    

  CC vs. CT         Overall           8           0.981          0.811--1.186   0.841          11.000                 35.808   0.590    

  Co-Dominant       Caucasoid         6           1.021          0.813--1.283   0.857          9.283                  40.354   0.918    

  CT vs. TT         Overall           7           1.031          0.798--1.331   0.817          4.000                  0.000    0.182    

  Co-Dominant       Caucasoid         6           1.093          0.778--1.534   0.609          4.087                  0.000    0.536    
  ---------------------------------------------------------------------------------------------------------------------------------------------

![Forest plot of rs1760944 polymorphism in APEX1 and risk to breast cancer (TT vs. CT) (the model adopted was marked by black frame)](oncotarget-09-16220-g004){#F4}

![Forest plot of rs1760944 polymorphism in APEX1 and risk to breast cancer (TT vs. CT+CC) (the model adopted was marked by black frame)](oncotarget-09-16220-g005){#F5}

The mutations in rs1130409 did not relate to the risk of developing BC, but T mutated to G in rs1760944 could increase the risk of developing BC in the Mongoloid race. There are insufficient studies which are focused on the relationship of rs1760944 and BC susceptibility outside the Mongoloid population, which restricted the meta-analysis on Mongoloid populations, compared to that done for the Caucasoid and Negroid populations (Table [3](#T3){ref-type="table"}).

###### Summary about meta-analysis results of SNPs in APEX1 gene and risk of breast cancer

  ------------------------------------------------------------------------------------------------------------------------------------------
  SNP            Genetic\          Race        *n*            OR (95% CI)    Homogeneity    *P* for Publication\                     
                 Models                                                                     Bias                                     
  -------------- ----------------- ----------- -------------- -------------- -------------- ---------------------- -------- -------- -------
  Rs1130409\     TT + CT vs. CC\   Overall     13             1.012          0.773--1.325   0.932                  74.000   83.730   0.412
  TT/ TG/ GG     (Dominant)                                                                                                          

  Caucasoid      7                 0.942       0.604--1.469   0.794          60.567         90.094                 0.778             

                 Mongoloid         5           1.076          0.779--1.486   0.658          13.195                 69.684   0.747    

  TT vs. CT+CC   Overall           13          0.918          0.783--1.075   0.288          37.000                 67.181   0.703    

  (Recessive)    Caucasoid         7           0.840          0.623--1.132   0.251          30.948                 80.613   0.144    

                 Mongoloid         5           0.966          0.837--1.115   0.637          5.348                  25.199   0.342    

  T vs. C        Overall           13          0.967          0.831--1.124   0.658          75.000                 83.977   0.363    

  (Allele)       Caucasoid         7           0.908          0.688--1.199   0.4-95         69.148                 91.323   0.786    

                 Mongoloid         5           1.005          0.903--1.118   0.928          5.635                  29.015   0.073    

  TT vs. CT      Overall           13          0.878          0.753--1.026   0.101          30.000                 60.592   0.133    

  Co-Dominant    Caucasoid         7           0.799          0.61--1.047    0.104          21.625                 72.254   0.739    

                 Mongoloid         5           0.937          0.775--1.133   0.503          8.105                  50.650   0.295    

  CT vs. CC      Overall           13          1.074          0.812--1.421   0.615          69.000                 82.658   0.944    

  Co-Dominant    Caucasoid         7           1.042          0.665--1.633   0.858          53.503                 88.786   0.978    

                 Mongoloid         5           1.111          0.764--1.614   0.582          15.600                 74.359   0.972    

  Rs1760944\     TT+CT vs. CC      Overall     4              1.000          0.840--1.192   0.996                  7.000    55.865   0.899
  TT/ CT /CC                                                                                                                         

  (Dominant)     Mongoloid         3           1.021          0.854--1.221   0.816          5.387                  62.873   0.609    

  TT vs. CT+CC   Overall           4           1.265          1.086--1.474   0.003          4.000                  23.638   0.763    

  (Recessive)    Mongoloid         3           1.227          1.044--1.441   0.013          2.511                  20.344   0.943    

  T vs. C        Overall           4           1.106          1.001--1.222   0.049          6.000                  50.892   0.638    

  (Allele)       Mongoloid         3           1.098          0.989--1.219   0.081          5.909                  66.153   0.609    

  TT vs. CT      Overall           4           1.067          0.772--1.478   0.122          3.000                  4.848    0.359    

  Co-Dominant    Mongoloid         3           1.241          1.045--1.473   0.014          1.201                  0.000    0.727    

  CT vs. CC      Overall           4           0.913          0.757--1.101   0.337          6.000                  46.736   0.882    

                 Co-Dominant       Mongoloid   3              0.938          0.775--1.135   0.511                  3.641    45.072   0.279
  ------------------------------------------------------------------------------------------------------------------------------------------

Table [4](#T4){ref-type="table"} shows a CC genotype of rs1052133 played a protective role in the development of BC in Mongoloid and Caucasoid race populations (Figures [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}).

###### Summary about meta-analysis results of SNPs in OGG1 gene and risk of breast cancer

  -------------------------------------------------------------------------------------------------------------------------------------
  SNP            Genetic\        Race      *n*            OR(95% CI)     Homogeneity    *P* for Publication\                    
                 Models                                                                 Bias                                    
  -------------- --------------- --------- -------------- -------------- -------------- ---------------------- -------- ------- -------
  rs1052133\     CC+CG vs. GG\   Overall   20             0.767          0.611--0.962   0.021                  128      85.21   0.478
  CC/ CG/ GG     (Dominant)                                                                                                     

  Caucasoid      11              0.646     0.376--1.107   0.112          111.303        91.016                 0.735            

                 Mongoloid       8         0.877          0.770--0.998   0.047          11.056                 36.687   0.425   

  CC vs .CG+GG   Overall         22        1.215          0.819--1.802   0.334          133                    84.168   0.665   

  (Recessive)    Caucasoid       13        1.224          0.962--1.556   0.100          112.479                89.331   0.139   

                 Mongoloid       8         0.955          0.749--1.217   0.709          11.056                 36.687   0.391   

  C vs. G        Overall         20        1.002          0.897--1.119   0.968          115                    83.47    0.841   

  (Allele)       Caucasoid       11        0.994          0.818--1.208   0.954          87.007                 88.507   0.211   

                 Mongoloid       8         1.006          0.880--1.149   0.932          26.557                 73.642   0.480   

  CC vs.CG       Overall         20        0.818          0.677--0.987   0.036          59                     67.958   0.488   

  Co-Dominant    Caucasoid       11        0.734          0.492--1.093   0.128          51.521                 80.591   0.577   

                 Mongoloid       8         0.855          0.749--0.976   0.020          7.037                  0.521    0.583   

  CG vs. GG      Overall         20        0.752          0.595--0.951   0.017          122                    84.455   0.289   

  Co-Dominant    Caucasoid       11        0.613          0.352--1.070   0.085          105.605                90.531   0.131   

                 Mongoloid       8         0.886          0.777--1.010   0.052          10.097                 30.673   0.735   
  -------------------------------------------------------------------------------------------------------------------------------------

![Forest plot of rs1052133 polymorphism in OGG1 and risk to breast cancer (CC+CG vs. GG) (the model adopted was marked by black frame)](oncotarget-09-16220-g006){#F6}

![Forest plot of rs1052133 polymorphism in OGG1 and thus risk to breast cancer (CG vs. GG) (the model adopted was marked by black frame)](oncotarget-09-16220-g007){#F7}

![Forest plot of rs1052133 polymorphism in OGG1 and thus risk to breast cancer (CC vs. GG) (the model adopted was marked by black frame)](oncotarget-09-16220-g008){#F8}

Sensitivity analysis demonstrated all the results were robust, and no significant publication bias was found.

DISCUSSION {#s4}
==========

This study quantitatively summarized the association between 8 SNPs on 4 BER genes and the risk of developing BC, by pooling the data from 69 papers with 33760 BC cases and 33252 control individuals. To the best of our knowledge, this paper is novel in its discussion in terms of the difference to the susceptibility to BC in different races. Overall, the results of this paper found that the mutations of rs25487 on the XRCC1 gene, rs1760944 on APEX1 and rs1052133 on the OGG1 gene were significantly related with susceptibility to BC.

Rs25487 on the XRCC1 gene (also known as Gln399Arg, and A allele encodes the Gln amino acid) was the polymorphism most studied in the risk of cancers. Rs25487 participates in coding of BRCT I domains of XRCC 1, which is one of the interaction domains of BRCA 1 protein \[[@R79]\]. BRCA 1 has been proved to be a predict gene for hereditary BC, it can suppress developing of breast cancer in humans \[[@R80], [@R81]\] This meta-analysis found populations with A allele could significantly reduce the risk of developing BC. Similar findings are presented in other cancers studies. For instance, in two studies carried on Americans and Koreans, the rs25487(A/A) genotype significantly reduces the risk of both basal cell and squamous cell cancers \[[@R82], [@R83]\]. A meta-analysis found the G allele is one of the risk factors in developing of Glioma in Asians \[[@R84]\]. Another meta-analysis carried out on a Chinese population found XRCC1 Arg399Gln polymorphism is not associated with BC (at the 5% level) but indicated a borderline association \[[@R85]\].

In human cells, APE1 gene, located on chromosome 14, encodes the primar AP endonuclease. AP sites is frequently happened in DNA molecules, which can help cells to recognize and repair DNA damage \[[@R86]\]. Rs1130409 and rs1760944 on the APE1 gene has been widely researched with respect to its role in cancer susceptibility \[[@R87]--[@R89]\]. By pooling 4 studies (3 on Chinese populations and 1 on an Iran population), this meta-analysis found the rs1760944 (also known as -- 656T \> G) variants was associated with an incaresed risk of developing BC in Mongoloid populations, or more specifically, in the Chinese population. Rs1760944 polymorphism is located on Polymorphisms in a promoter region and is located −141bp upstream from the transcription initiation site. Variants in the promoter region, or 3'UTR, of a gene may influence its function and lead to abnormal protein expression. Function studies have proved that Rs1760944 mutation can influence its activity of communicating to other BER proteins \[[@R69]\].

The key role of OGG1 protein is to cleave 8-hydroxyguanine. \[[@R90]\] Rs1052133, also known as Ser326Cys, is a SNP on the OGG1 gene, and the minor (G) allele, encoding the cysteine. This paper found that in contrast to the GG genotype, people who carried the CC or CG genotype had a lower risk of developing BC in both the Mongoloid and Caucasoid race populations. This study indicated that rs1052133 may follow a recessive inheritance pattern in BC susceptibility, because the OR of CC vs. GG genotypes was similar to CG vs. GG genotypes (results shown in Table [4](#T4){ref-type="table"}). Lee et al. (2015) found that ability of oxidative DNA damage repair was significant lower in GG genotype individuals than non-GG genotype individuals \[[@R91]\].

CONCLUSIONS {#s5}
===========

This study suggests that rs1052133, rs25487 and rs1760944 polymorphisms may influence individual susceptibility to risk of developing BC, and provides evidence which supports the idea that mutations of the DNA repair genes are associated to BC risk. The understanding of BC etiology and roles in the potential biological pathways linking DNA repair, ethnic background, environment and BC need to be studied further.

SUPPLEMENTARY MATERIALS TABLES {#s6}
==============================
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